Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
NCT ID: NCT06856993
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2021-12-22
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Differential Expression and Analysis of Peripheral Plasma Exosome miRNA in Patients With Myocardial Infarction
NCT04127591
REgiStry in Chinese yoUng pEople With Sudden Cardiac Death
NCT05713240
Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy
NCT07293338
Risk Factors Analysis for Acute Myocardial Infarction Patients
NCT05390658
Potential Diagnostic and Prognostic Value of microRNAs for the Patients of Acute Coronary Syndrome
NCT02755207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standardized medical care of cardiac arrest
The standardized medical care for cardiac arrest includes early cardiopulmonary resuscitation (CPR), defibrillation, advanced cardiac life support (ACLS), post-resuscitation care, and continuous monitoring of the patient's vital functions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* The patient had obvious clinical symptoms 24 hours before treatment
* Life expectancy exceeds 3 days
* Proxy of patients signs the informed consent form
* Comply with ACS diagnostic indicators recommended by ACC / AHA guidelines in 2016
Exclusion Criteria
* Death from accidental or intentional overdose
* Death from asphyxia
* Death is caused by chronic disease or terminal illness
* The patient died naturally
* Has participated in other clinical studies
* Immediate family members give up continuing treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hao Sun
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-SR-320
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.